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Pentablock copolymer micelle nanoadjuvants enhance cytosolic delivery
of antigen and improve vaccine efficacy while inducing low inflammation
Abstract
As the focus has shifted from traditional killed or live, attenuated vaccines towards subunit vaccines,
improvements in vaccine safety have been confronted with low immunogenicity of protein antigens. This issue
has been addressed by synthesizing and designing a wide variety of antigen carriers and adjuvants, such as
Toll-like receptor agonists (e.g., MPLA, CpG). Studies have focused on optimizing adjuvants for improved
cellular trafficking, cytosolic availability, and improved antigen presentation. In this work, we describe the
design of novel amphiphilic pentablock copolymer (PBC) adjuvants that exhibit high biocompatibility and
reversible pH- and temperature-sensitive micelle formation. We demonstrate improved humoral immunity in
mice in response to single dose immunization with PBC micelle adjuvants compared to soluble antigen alone.
With the motive of exploring the mechanism of action of these PBC micelles, we studied intracellular
trafficking of these PBC micelles with a model antigen and demonstrated that the PBC micelles associate with
the antigen and enhance its cytosolic delivery to antigen presenting cells. We posit that these PBC micelles
operate via immune-enhancing mechanisms that are different from that of traditional Toll-like receptor
activating adjuvants. The metabolic profile of antigen presenting cells stimulated with traditional adjuvants
and the PBC micelles also suggests distinct mechanisms of action. A key finding from this study is the low
production of nitric oxide and reactive oxygen species by antigen presenting cells when stimulated by PBC
micelle adjuvants in sharp contrast to TLR adjuvants. Together, these studies provide a basis for rationally
developing novel vaccine adjuvants that are safe, that induce low inflammation, and that can efficiently deliver
antigen to the cytosol.
Keywords
Adjuvant, Micelles, Block Copolymers, Antigen delivery, Antibody-mediated immunity, Immunometabolism
Disciplines
Biomaterials | Medical Pharmacology | Nanomedicine | Veterinary Toxicology and Pharmacology
Comments
This document is the unedited Author’s version of a Submitted Work that was subsequently accepted for
publication in ACS Biomaterials Science and Engineering, copyright © American Chemical Society after peer
review. To access the final edited and published work see DOI: 10.1021/acsbiomaterials.8b01591.
Authors
Sujata Senapati, Ross J. Darling, Darren Loh, Ian C. Schneider, Michael J. Wannemeuhler, Balaji Narasimhan,
and Surya K. Mallapragada
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/chem_pubs/1105
1Pentablock copolymer micelle nanoadjuvants 
enhance cytosolic delivery of antigen and improve 
vaccine efficacy while inducing low inflammation
Sujata Senapati1,4, Ross J. Darling2,4, Darren Loh3, Ian C. 
Schneider1,4, Michael J. Wannemuehler2,4, Balaji Narasimhan1,4*, and 
Surya K. Mallapragada1,4,*
1Department of Chemical and Biological Engineering, Iowa State 
University, Ames, IA, 50011, USA
2Department of Veterinary Microbiology and Preventive Medicine, 
Iowa State University, Ames, IA, 50011, USA
3Department of Chemical and Biological Engineering, Johns Hopkins 
University, Baltimore, MD, 21218, USA
4Nanovaccine Institute, Iowa State University, Ames, IA, 50011, 
USA
*Correspondence:
Surya Mallapragada (suryakm@iastate.edu) and Balaji Narasimhan (nbalaji@iastate.edu)
Page 1 of 60
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2Page 2 of 60
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3ABSTRACT
As the focus has shifted from traditional killed or live, 
attenuated vaccines towards subunit vaccines, improvements in 
vaccine safety have been confronted with low immunogenicity of 
protein antigens. This issue has been addressed by synthesizing 
and designing a wide variety of antigen carriers and adjuvants, 
such as Toll-like receptor agonists (e.g., MPLA, CpG). Studies 
have focused on optimizing adjuvants for improved cellular 
trafficking, cytosolic availability, and improved antigen 
presentation. In this work, we describe the design of novel 
amphiphilic pentablock copolymer (PBC) adjuvants that exhibit high 
biocompatibility and reversible pH- and temperature-sensitive 
micelle formation. We demonstrate improved humoral immunity in 
mice in response to single dose immunization with PBC micelle 
adjuvants compared to soluble antigen alone. With the motive of 
exploring the mechanism of action of these PBC micelles, we studied 
intracellular trafficking of these PBC micelles with a model 
antigen and demonstrated that the PBC micelles associate with the 
antigen and enhance its cytosolic delivery to antigen presenting 
cells. We posit that these PBC micelles operate via immune-
enhancing mechanisms that are different from that of traditional 
Toll-like receptor activating adjuvants. The metabolic profile of 
antigen presenting cells stimulated with traditional adjuvants and 
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4the PBC micelles also suggests distinct mechanisms of action. A 
key finding from this study is the low production of nitric oxide 
and reactive oxygen species by antigen presenting cells when 
stimulated by PBC micelle adjuvants in sharp contrast to TLR 
adjuvants. Together, these studies provide a basis for rationally 
developing novel vaccine adjuvants that are safe, that induce low 
inflammation, and that can efficiently deliver antigen to the 
cytosol. 
KEYWORDS
Adjuvant, Micelles, Block Copolymers, Antigen delivery, Antibody-
mediated immunity, Immunometabolism
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5INTRODUCTION
Adjuvants have been used for almost seven decades to augment 
immune responses to antigens in subunit vaccines1–4. However, only 
a few, such as alum and monophosphoryl lipid A (MPLA), are 
currently approved by the United States Food and Drug 
Administration for use in human vaccines5. These adjuvants suffer 
from several limitations, including high reactogenicity, failure 
to provide cell-mediated immunity, and variability in the 
induction of immune responses in older adults6–8. Most vaccines or 
adjuvants that are currently approved or in pre-clinical trials 
work by the stimulation of pathogen recognition receptors (PRRs) 
on antigen presenting cells (APCs). This leads to the induction of 
inflammatory signals, such as cytokines, superoxides, and nitric 
oxide (NO)5. However, due to immunosenescence in older adults, this 
cytokine milieu is highly imbalanced leading to a state of 
“inflamm-aging” and an overproduction of harmful oxide analytes9,10. 
While the traditional approach for vaccine design works in most 
cases, the presence of inflammaging in older adults necessitates 
the development (and exploration of mechanism of action) of novel 
vaccine adjuvants that do not induce the production of harmful 
analytes while stimulating the immune system.
A significant amount of research has been focused on improving 
transport and delivery of antigens and adjuvants to APCs11,12. These 
antigens can be processed by APCs and presented via MHC I or MHC 
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6II pathway for the induction of effective T and B cell responses12. 
Studies have focused on pH-sensitive amphiphilic polymer-based 
vaccine delivery vehicles to enhance antigen presentation to the 
MHC I pathway and to induce CD8+ T cell responses that can be 
beneficial for enhancing the breadth of protection against 
intracellular pathogens13–15. In particular, cationic polymeric 
systems have been shown to enhance endosomal escape of the antigen 
due to the proton sponge effect and enhance cytosolic uptake of 
the antigen16–18. 
Amphiphilic pentablock copolymers based on Pluronic F127®, 
poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), and 
cationic blocks such as poly(diethylaminoethylmethacrylate) 
(PDEAEM) have been previously studied for drug delivery and gene 
delivery19–21. Aqueous solutions of these polymers can form 
spherical micelles (about 30 nm in diameter) and at higher 
concentrations (>20 wt.% polymer) form physical hydrogels in 
response to both temperature and pH22,23. The observation that small 
particle sizes of antigen delivery systems can enhance 
internalization by APCs has been widely exploited by different 
nanoparticle systems24–27. Therefore, a polymer system having both 
sub-100 nm size and stimuli responsiveness can be extremely 
beneficial. Hydrogels based on these pentablock copolymers (PBC) 
have been shown to provide sustained release of structurally stable 
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7antigen in vivo and enhance anti-ovalbumin (Ova) antibody 
responses28,29. We have also demonstrated in previous influenza 
virus challenge experiments that these PBC formulations can 
enhance neutralizing antibody titers that effected a reduction in 
viral load in lungs and exhibit improved vaccine efficacy in mice30. 
In this study, we prepared low concentration PBCs in aqueous 
solutions to form micelles without gelation that still enhanced 
antibody responses. This also eliminates any potential 
inflammatory responses associated with the high polymer 
concentrations needed to form gels31. However, little is known 
about the mechanism of action of PBC micelle adjuvants; how they 
interact with innate immune cells; and how these interactions lead 
to the induction of effective adaptive immunity. 
In this work, to explore the mechanism of action of these PBC 
micelles, we characterized antigen-micelle complexes using Forster 
Resonance Energy Transfer (FRET) spectroscopy and microscopy and 
showed that Ova associated with the micelles in the solution phase 
and that the PBC micelles enhanced Ova delivery to the cytosol in 
vitro in APCs. We also studied the stimulation of APCs with 
antigen-containing PBC micelles using three different approaches. 
In the first phase, we analyzed the upregulation of co-stimulatory 
molecules and cytokine secretion profile from APCs. Next, we 
measured the oxygen consumption rate by the mitochondria of APCs 
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8as a measure of stimulation. We analyzed the mitochondrial 
respiration and metabolic profile in comparison to the TLR agonist 
lipopolysaccharide (LPS). Finally, we studied the amount of innate 
effector molecule (such as NO and reactive oxygen species (ROS)) 
secretion by APCs upon stimulation with PBC micelles. 
Collectively, the studies presented here focus on the analysis of 
the responses of innate immune cells stimulated by novel PBC 
micelle adjuvants in order to understand their mechanism of action 
so as to develop safe and effective adjuvants with low inflammatory 
potential. 
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9EXPERIMENTAL SECTION
Materials
N,N-(diethylamino)ethyl methacrylate (DEAEM), Pluronic F127, 
Poly(vinyl alcohol) (PVA, MW=9,000-10,000 g/mol), and ovalbumin 
(Ova, 44 kDa) were purchased from Sigma-Aldrich (St. Louis, MO). 
Alum (Alhydrogel®) and dyes for imaging and labeling were purchased 
from InVivogen (San Diego, CA). All other materials were purchased 
from Fisher Scientific (Pittsburgh, PA). 
Methods
Pentablock copolymer synthesis and characterization
Pentablock copolymer (PDEAEM-PEO-PPO-PEO-PDEAEM) was synthesized 
by atom transfer radical polymerization (ATRP) as reported 
previously22. This method utilizes a difunctional macroinitiator 
prepared from commercially available Pluronic® F127. This was 
dissolved in tetrahydrofuran and reacted overnight with 
triethylamine and 2-bromoisobutyryl. The product was precipitated 
in n-hexane. The 2-bromo propionate Pluronic F127 was analyzed 
using 1H NMR to confirm the end group functionalization. Next, the 
macroinitiator and the monomer DEAEM were used to synthesize the 
pentablock copolymer by ATRP utilizing copper (I) oxide 
nanoparticles as the catalyst and N-propylpyrilidinemethanamine 
(NPPM) as the complexing ligand. Cuprous oxide nanoparticles used 
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10
as catalyst were synthesized as previously described32. 1H NMR 
spectra of the resulting polymer were used to determine molecular 
weight.
Labeling of PBC and antigen with fluorescent dyes
The PBC and Ova were labeled with dyes to detect them 
fluorescently. We utilized an Alexa Fluor 594 protein labeling kit 
that utilizes a succinimidyl ester moiety to react with the primary 
amines of the proteins (Molecular Probes, Eugene, OR) for labeling 
ovalbumin according to the manufacturer’s protocol. For labeling 
the PBC we functionalized the end groups with azide following 
previously described28. We then utilized azide-alkyne click 
chemistry to attach alkyne functionalized Alexa Fluor 647 (Thermo 
Fisher Scientific, Waltham, MA) according to the manufacturer’s 
protocol. 
PBC hydrogel and micelle formulations
A stock solution of 30% PVA was prepared in phosphate-buffered 
saline (PBS). For the hydrogel formulation, this stock solution 
was added to obtain a final concentration of 15 wt.% PVA, 5.9 wt.% 
Pluronic® F127 and 4.1 wt.% PBC in PBS. For the micelle formulation, 
a similar procedure was followed to obtain a final concentration 
of 7.5 wt.% PVA, 2.95 wt.% Pluronic F127 and 2.05 wt.% PBC in PBS. 
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11
A micelle formulation with the fluorescently labelled PBC was also 
prepared and used in experiments as required.
Animals
Female C57BL/6 or BALB/c mice (6-7-week-old) were purchased from 
Charles River Laboratories (Wilmington, MA). The Institutional 
Animal Care and Use Committee (IACUC) at Iowa State University 
approved all protocols involving animals. 
Immunizations and evaluation of antibody titers
To evaluate antibody responses, C57BL/6 or BALB/c mice were 
subcutaneously immunized with 100 µL of the micelle formulation, 
100 µL of hydrogel formulation, or alum in a 1:1 ratio with Ova, 
all containing 50 µg of Ova. Control animals were immunized with 
soluble Ova  in PBS (50 µg in 100 µL) (i.e., no adjuvant). Serum 
samples were collected via the saphenous vein at 21 days and 35 
days post-immunization. Enzyme-linked immunosorbent assay (ELISA) 
was performed to measure the total anti-Ova total IgG titers. 
Briefly, high binding 96-well ELISA plates were coated with Ova 
overnight and blocked with 2% w/v gelatin (BD DifcoTM, Fisher 
Scientific, Hampton, NH) in 0.05% Tween-PBS solution the following 
day. Serum samples were added at a dilution of 1:200 and diluted 
1:2 across the plate. After incubation and washing, alkaline-
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12
phosphatase-conjugated anti-mouse IgG (H+L) (Jackson 
ImmunoResearch, Westgrove, PA) was added and incubated for two 
hours before adding substrate buffer and reading the plate at 405 
nm. Titer was recorded as the last dilution that exhibited an 
optical density greater than twice the background optical density.
Generation of bone marrow dendritic cells (BMDCs) and bone marrow 
macrophages (BMMs) 
Bone marrow was harvested from femurs and tibia of BALB/c mice 
and differentiated to dendritic cells using a standard protocol33. 
Briefly, the bone marrow was flushed out of the bones using a 
syringe with 5 mL of RPMI media containing 1% (1 g/100 mL) 
pen/strep. Granulocyte macrophage colony stimulating factor (GM-
CSF) was added on the 1st day of culture at the concentration of 
1ng/mL . GM-CSF and medium was refreshed on days 3, 6 and 8 of 
culture by exchanging 10 mL of spent medium with fresh medium 
containing GM-CSF. BMDCs were harvested on day 10 and used in 
subsequent assays. The same protocol was followed for BMMs except 
using DMEM medium and macrophage colony stimulating factor (M-CSF) 
as the cytokine at a concentration of 1 ng/mL.
Confocal microscopy
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13
J774 macrophage cell line and BALB/c-derived BMDCs were used to 
analyze the cellular internalization of antigen-containing 
micelles using confocal microscopy. Cells were cultured on and 
allowed to adhere to round glass coverslips (VWR, Radnor, PA) in 
24 well flat-bottom cell culture plates overnight. For J774s, since 
they are adherent, no coating on the coverslips was used. However, 
for the BMDCs we treated the coverslips with poly D-lysine for 12 
hours before cell culture. The cells were incubated for 15 min, 30 
min, 2 hours and 12 hours with the labeled Ova solution (20 μg/mL) 
and the micelle formulation (12.5 μg/mL) consisting of labeled 
PBC, together and separately as controls. For the groups treated 
with micelle-Ova complex, the micelle and Ova solutions were co-
incubated for an hour before adding them to the cells. The cells 
were then stained with Hoescht 33342 solution for nuclear staining 
(ThermoFisher Scientific) as described in the commercial protocol. 
Anti-mouse LAMP-1 (1D4B) (Developmental Studies Hybridoma Bank, 
University of Iowa) was used to stain lysosomes in BMDCs. The cells 
were then fixed and the cover slips were mounted on microscopic 
slides (VWR, Radnor, PA). A Leica SB5 X MP confocal microscope was 
used to image the cell samples and the images were analyzed using 
LAS AF software (Leica Microsystems, Wetzlar, Germany). 
FRET spectroscopy and microscopy 
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14
AF594 tagged to Ova and AF647 tagged to the PBC (Forster radius, 
R0= 8.5 nm) acted as the donor and acceptor fluorophore, 
respectively for FRET analysis. Solutions with 12.5 μg/mL of PBC 
micelle formulation and 20 μg/mL of Ova were mixed together or 
added separately to measure the fluorescence spectra using a dual 
monochromator spectrofluorometer (Fluoromax-4, Horiba Jobin Yvon, 
Kyoto, Japan) with slit width of 3 nm at the excitation of the 
donor (590 nm) and emission wavelengths for the two fluorophores 
(AF594 Em: 610 nm and AF647 Em: 660 nm). 
For FRET microscopy, Leica SB5 X MP confocal microscope was used 
for slides prepared in a similar manner as confocal microscopic 
imaging using the same concentrations of the PBC micelle and Ova 
solutions. However, the settings in the microscope were changed 
according to the procedure used to measure sensitized emission for 
FRET34, which involves the measurement of acceptor emission change 
with the addition of the donor. The different images taken in order 
were: (a) FRET sample images in the FRET channel (donor excitation 
and acceptor emission), donor channel (donor excitation and donor 
emission), acceptor channel (acceptor excitation and acceptor 
emission); (b) Acceptor only sample image in the acceptor channel; 
and (c) Donor only sample image in the donor channel. The last two 
images were taken to correct for the spectral bleed-throughs in 
the channel to subtract the amount of radiation detected in the 
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FRET channel which is not due to the energy transfer. The 
instrument settings were kept constant throughout the imaging. The 
bleed-through was calculated using a linear regression obtained by 
the FRET and colocalization analyzer plugin in ImageJ software 
(NIH, Bethesda, MD). Final FRET index images, heat maps in the 
“fire” Look-Up Table (LUT) and mean FRET indices  were generated 
by selecting regions of interest (ROIs) in the images where cells 
were present. 
In vitro APC stimulation
BALB/c-derived BMDCs, BMMs, and J774s were plated at 5 x 105 
cells/well in a 96-well round bottom tissue culture plate in 200 
L of complete RPMI 1640 medium with 1% pen/strep (1 g/100 mL). 
Stimulations were carried out overnight or for 48 hours using 12.5 
g/mL of micelles, 1 g/mL of LPS, or untreated control wells. 
Supernatants were collected for cytokine analysis and NO 
quantification, and cells were harvested (using cell scrappers for 
BMMs and J774s) for cell surface maker expression and mitochondrial 
and cell superoxide production by flow cytometry. 
Cytokine secretion assay
The cell-free supernatants collected after stimulating the 
different cellular populations for 48 hours were used  to evaluate 
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the levels of cytokine secretions. BioRad BioPlex 200 system 
(Hercules, CA) was used to analyze IL-6, TNF-α, IL-1β, IL-12 and  
IFNγ secretions. 
Flow cytometry
Costimulatory marker expression on APCs was evaluated using flow 
cytometry. BMDCs at a concentration of 5 x 105 cells/200 μL were 
aspirated from a 96 well plate and transferred to polystyrene FACS 
tubes. Prior to labeling with specific monoclonal antibodies, Fc 
receptors on DCs were blocked to prevent non-specific antibody 
binding by incubating the cells with 100 µg/mL of rat IgG (Sigma 
Aldrich, St. Louis, MO) and 10 µg/mL of anti-CD16/32 (eBioscience). 
Subsequently, APCs were stained with fluorescently conjugated 
antibodies for CD80 (Biolegend, PerCP-Cy5.5, clone 16-10A1), CD86 
(eBioscience, FITC, clone GL1), CD40 (eBioscience, APC, clone 
1C10), CD11c (Biolegend, APC-Cy7, clone N418), MHCII (eBioscience, 
AF700, clone M5/114.15.2) diluted at 1:50 v/v in FACS buffer . 
Mitochondrial superoxide production was evaluated using live 
cells stained with MitoSOX Red (ThermoFisher Scientific) according 
to manufacturer’s specifications. The amount of reactive oxygen 
species (ROS) produced by the BMDCs was measured using CellROX 
Green (ThermoFisher Scientific) according to the manufacturer’s 
protocol. 
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Fluorescent activated cell sorting (FACS) was used to quantify 
the internalization of protein and micelles into BMDCs and a 
macrophage cell line J774. The cells were treated with either the 
labeled Ova (20 μg/mL) or the PBC micelles (12.5 μg/mL) , or the 
micelle-Ova complex obtained after an hour of incubation of the 
solutions, for multiple time intervals (15 min, 30 min, 2 hours 
and12 hours). After the incubation, the cells were transferred to 
FACS tubes and suspended and washed in FACS buffer to remove the 
excess dye not taken up by the cells. All the samples for flow 
cytometry except the MItoSOX and CellROX samples were fixed using 
BD stabilizing fixative (BD Bioscience, Franklin Lakes, NJ). Data 
was collected on a FACSCanto II (BD Bioscience, Franklin Lakes, 
NJ), and analyzed using FlowJo (Flowjo LLC, Ashland, OR).
Extracellular flux analysis 
Metabolic effect of stimulation of BMDCs was measured using two 
assays. For measurement of oxidative phosphorylation, the oxygen 
consumption rate (OCR) was analyzed by performing an overnight 
stimulation of BMDCs with either 12.5 µg/mL of PBC micelles, 1 
µg/mL of LPS, or untreated control, was carried out in 5 mL 
polypropylene tubes. 2.5 x 105 stimulated BMDCs were seeded into 
Cell-Tak (Corning, Corning NY) coated Seahorse plates and a 
mitochondrial stress test (MST) was conducted according to 
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manufacturer’s specifications using kit concentrations of 1 µM 
oligomycin, 2 µM FCCP, and 0.5 µM rotenone and antimycin (Agilent, 
Santa Clara, CA). 
For measurement of acute metabolic responses and glycolysis 
(demonstrated by extracellular acidification rate, ECAR) upon 
stimulation, untreated BMDCs were seeded into Cell-Tak (Corning, 
Corning NY) coated seahorse plates at a density of 2.5 x 105 
untreated BMDCs per well. Baseline metabolic activity readings 
were measured, and wells were stimulated with 12.5 µg/mL of 
micelle, 1 µg/mL of LPS, or medium control and metabolic 
measurements are taken over the course of the assay. All metabolic 
phenotyping was conducted on a Seahorse XFe24 (Agilent, Santa 
Clara, CA).
Nitric oxide quantification
Nitric oxide (NO) in supernatants obtained from BMDCs, BMMs and 
J774 cells stimulation for 48 hours was quantified using a Griess 
assay. A sodium nitrite standard curve was created with 
concentrations ranging from 100 µM to 0 µM. 100 µL of Griess 
reagent (Cat. No. 03553, Sigma-Aldrich) was added to 100 µL of 
standard or sample supernatant in a 96 well microtiter plate. 
Samples were allowed to react for 15 minutes at room temperature 
and read at 540 nm on a SpectraMAX 190 (Molecular Devices, 
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Sunnyvale, CA) plate reader. Experimental nitrite concentrations 
were calculated using a linear regression method.
Statistics
For the antibody titer data, statistical significance was 
determined using One-way ANOVA and Tukey-post t test on the log 2 
transformed  titers using GraphPad (Prism 7.0, GraphPad Software, 
La Jolla, CA). For all other experiments, statistical significance 
was determined using one-way ANOVA analysis of the respective 
values using GraphPad and p-values 0.05 were considered ≤  
significant. 
Results 
PBC micelle nanoadjuvant enhances antibody-mediated immunity
The ATRP method yielded PBC with outer cationic PDEAEM blocks 
having a molecular weight of 14,680 g/mol as determined by 1H NMR. 
The micelle formulation prepared from PBC was administered to mice 
with Ova to evaluate the induction of humoral immune responses. In 
addition, separate groups of mice were administered either soluble 
ovalbumin (sOVA), alum+Ova or a hydrogel formulation (as used in 
previous studies), all containing 50 µg of Ova29. We observed a 
nine-fold increase in anti-Ova antibody titers in sera of mice 
Page 19 of 60
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
20
immunized with micelles when compared to sOVA at two weeks post-
immunization (p.i.) (Figure 1). 
Figure 1. Pentablock copolymer (PBC) micelles enhanced antibody 
titers in C57BL/6  mice 2- and 4-weeks post-immunization. Serum 
collected at 14 and 28 dpi were used to evaluate anti-OVA total 
IgG titers using ELISA. Statistical differences between the 
treatment groups within each time-point were determined using one-
way ANOVA and Tukey-post t test on the log 2 transforms of the 
titer dilution values. * indicates p<0.05 and **** indicates 
p<0.0001. Data are representative of two independent experiments 
with C57BL/6 mice and one independent experiment with BALB/c mice 
with 4-5 animals in each experiment per treatment group.
This fold-increase was sustained through four weeks p.i. In 
addition, we observed a significant increase in anti-OVA antibody 
titers in sera of animals immunized with the hydrogel formulation 
over the sOVA, consistent with our previous studies29. However, 
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there were no significant differences observed between the micelle 
and hydrogel formulations, indicating that the PBC micelle 
enhanced humoral immunity even at much lower polymer concentration 
(compared to the hydrogel formulation). This suggests that the 
thermogelation or depot formation of the PBC hydrogel at the site 
of injection is not the only mechanism of action of this adjuvant. 
We also observed that the antibody titers in the animals immunized 
with alum+Ova, which were not significantly different from the 
titers induced in the animals immunized with PBC micelles at two 
weeks p.i, became significantly different (about four-fold higher) 
at four weeks p.i. We also performed anti-Ova IgM titers (data not 
shown) that showed similar trends as IgG. 
PBC micelle nanoadjuvants exhibit cytosolic uptake of antigen by 
BMDCs and J774 cells
To understand the mechanism of the action of these PBC micelles 
and identify factors that may contribute to the enhancement in 
humoral immunity when immunized with micelles, we decided to first 
probe their interaction with the APCs. Internalization of proteins 
or peptides by the APCs is the first step in the triggering of 
immune signaling to generate an immune response35,36. We studied the 
internalization of OVA-containing micelles by BMDCs and J774 cells 
using confocal microscopy. We observed that the micelles (cyan) 
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and ovalbumin (red) were internalized efficiently by both the cell 
types into the cytosol after a 30 min incubation time and stayed 
the same until the 12-hour incubation time (Figure 2, SI Figure 
2). However, we did not observe any internalization at the 15 min 
time point (SI Figure 2). After 12 hours of incubation, we could 
observe  antigen in BMDCs co-localized with the lysosomes (showed 
in green, Figure 2A).However, most of the antigen was distributed 
across the cytosol indicating antigen release from the micelles.  
In addition, due to their amphiphilic nature, we also observed a 
large amount of micelles interacting with the cell membrane, 
especially in the J774 cells starting at 15 min until after 12 
hours of incubation. We also analyzed the cells that had 
incorporated micelles using FACS. Almost 100% of the BMDCs and 
J774 cells were positive for the micelles as soon as 15 min and 
the labeling remained stable for at least 12-hours as indicated by 
the clear shifts in the population in the flow cytometry plots (SI 
Figure 1). The mean fluorescence intensity (MFI) of the micelle-
positive cell population however, increased from 15 min to 12 hours 
for both BMDCs and J774 cells. 
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Figure 2. Pentablock copolymer (PBC) micelles efficiently traffic 
antigen to the cytosol. A) Bone marrow derived dendritic cells 
(BMDCs) and B) J774 cells were incubated with micelles and 
ovalbumin (i.e., antigen) for 12 hours over glass coverslips. Cell 
components were stained following the incubation and cells were 
fixed and transferred to glass slides for imaging. Scale bars 
indicate 5 μm in A and 50 μm and 5 μm in the first four and last 
columns of B, respectively. Nuclei were stained with Hoescht 
(blue), lysosomes were stained with anti-LAMP-1 (green). Ovalbumin 
antigen (AF594) and PBC micelles (AF647) are denoted by red and 
cyan, respectively. Data are representative of four independent 
experiments. 
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PBC micelle nanoadjuvants associate with antigen and enhance their 
uptake
Next, we assessed the nature of interaction of the PBC micelles 
with the antigen using FRET. We first incubated micelles with Ova 
labeled with dyes that exhibit FRET in solution phase for 15 
minutes and studied the fluorescence spectrum of three solutions: 
(a) micelles only, (b) Ova only, and (c) micelles + Ova. FRET 
occurs if the donor and acceptor fluorophores are spatially 
proximal (less than 10 nm)37. Upon occurrence of FRET, we observed 
a decrease in the intensity of donor fluorescence (at 610 nm for 
the dye tagged with ovalbumin) and an increase of almost the same 
magnitude in the acceptor intensity (at 660 nm the dye tagged with 
the micelles) when both were in solution together, compared to 
when they were in solution separately (Figure 3). These 
observations showed that the micelles associate with the antigen 
in solution phase. 
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Figure 3. Pentablock copolymer (PBC) micelles associated with 
ovalbumin in solution phase. Micelles (12.5 mg/mL) and ovalbumin 
(20 mg/mL) were labelled with AF647 and AF594, respectively. The 
fluorescence spectra were measured for micelles only, ovalbumin 
only, and micelles plus ovalbumin mixtures. Arrows indicate 
decrease in AF594 (donor) fluorescence and increase in AF647 
(acceptor) fluorescence. 
We then evaluated whether the same phenomenon occurs in the 
presence of immune cells. We incubated J774 cells and BMDCs with 
micelles and Ova at different concentrations overnight and 
included micelles-only and Ova-only controls. After removal of 
spectral bleed-throughs and analysis of the images as described in 
the Methods section, we obtained mean FRET indices. We observed 
the highest FRET indices for a polymer concentration of 12.5 µg/mL 
and protein concentration of 25 µg/mL (mean FRET index = 16.8 for 
BMDCs and = 9.6 for J774 cells, generated using the histograms) as 
shown in Figures 4A and 4B. The images generated by the FRET 
analyzer plug-in provided us with an estimate of the degree of 
FRET occurring34. We observed greater FRET (as indicated by the 
color in the images and the heat map) in BMDCs than in J774 cells. 
We also observed some areas of very high FRET in both cell types 
(indicated by magenta color in the images). 
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Figure 4. Pentablock copolymer (PBC) micelles associated with 
ovalbumin intracellularly and enhanced the uptake of ovalbumin in 
BMDCs. FRET microscopic analysis of A) BMDCs and B) J774 cells 
demonstrated strong association of micelles with protein with FRET 
indices of 16.8 and 9.6 respectively. Histograms in the far right 
represent the mean FRET indices with the heat map for the ‘fire’ 
Look-Up Table (LUT) used in the FRET index images. Excitation and 
emission wavelengths (Ex/Em) used to image are: Donor channel: 590 
nm/620 nm, Acceptor channel: 650 nm/665 nm and FRET channel: 590 
nm/665 nm.  C) Ovalbumin uptake was increased two-fold when 
delivered with micelles in BMDCs. Statistical significance was 
determined using unpaired t test. ** indicates p<0.002.
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We hypothesized that the association of the micelles with antigen 
may assist the antigen being carried into the cytosol. Therefore, 
we performed FACS with J774 cells and BMDCs stimulated with 
micelles and ovalbumin at the same concentration at which we 
observed the highest FRET. We observed about a two-fold increase 
in the antigen mean fluorescence intensity (MFI) when the BMDCs 
were incubated with both the micelles and antigen than with the 
antigen alone after 12-hours of incubation (Figure 4C). The amount 
of antigen delivered to the cells also increased from 15 min to 12 
hours of incubation and we observed significantly more antigen at 
the 1-hour and 2-hours incubation periods for BMDCs than after 15 
min or 30 min of incubation. (SI Figure 3). We observed a slight 
(although not significant) increase in antigen MFI when J774 cells 
were used. 
APC stimulation by PBC micelle nanoadjuvants
While these previous experiments provided us valuable information 
about micelle-antigen interactions, an understanding of how immune 
cells perceive the antigen when it is adjuvanted with micelles is 
necessary. The activation of APCs such as DCs is an important part 
of the induction of innate and adaptive immune responses. DCs are 
activated by recognition of damage associated molecular patters 
(DAMPs) or microbial associated molecular patterns (MAMPs), and 
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undergo maturation and upregulate different cell surface 
markers38,39. To characterize the same, we assessed the expression 
of CD40, CD80, CD86 and MHCII in BMDCs and BMMs using flow 
cytometry when stimulated with PBC micelles for 48 hours. Overall, 
we observed little to no significant upregulation of these markers 
in BMDCs (Figure 5) or BMMs (SI Figure 4) with PBC micelles, 
compared to negative controls. The positive control, LPS however, 
induced significantly higher levels of these surface markers, 
consistent with the literature40. 
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Figure 5. Pentablock copolymer (PBC) micelles did not activate 
innate immune cells as exhibited by cell surface markers expression 
and less inflammatory cytokines secretions. A) BALB/c-derived 
BMDCs and B) J774 cells at a concentration of 2.5  106 cells/mLwere 
stimulated with different treatment groups (PBC micelles at the 
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concentration of 12.5 μg/mL and LPS at 1 μg/mL) for 48 hours. Flow 
cytometry was used to measure the cell surface marker upregulation. 
Cytokine secretion was evaluated from the supernatants collected 
after stimulation. Data is expressed as mean with standard error 
of mean. Statistical differences were determined using one-way 
ANOVA. *indicates p<0.05, ** indicates p<0.005 and *** indicates 
p<0.0005.
We also analyzed the levels of different cytokine secretions by 
the APCs. The cytokine milieu often determines the fate of various 
immune responses. We did not observe any secretion of the pro-
inflammatory cytokines, IL-6, TNF-α, IL-1β, IL-12, IFNγ from BMDCs 
and BMMs (Figure 5, SI Figure 4 and data not shown) in response to 
the PBC micelle formulations. We observed very high levels of pro-
inflammatory cytokines secreted by APCs stimulated with LPS 
(Figure 5 and SI Figure 2). Altogether, these data demonstrate the 
low APC-stimulating characteristics of the PBC micelles unlike 
traditional TLR-agonist adjuvants, such as LPS.  
Immunometabolic profile of PBC micelle nanoadjuvants
Recent advances in the field of immunometabolism have described 
the relationship between DC activation and the corresponding 
metabolic changes41–43. Several hours post-exposure to TLR ligands, 
BMDCs exhibit a dramatic shift to a dependence on aerobic 
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glycolysis for survival and generation of ATP44. This effect is 
driven by the nitrosylation of electron transport chain (ETC) 
molecules after production of large amounts of NO as a result of 
encounter with TLR ligands45. As a result, BMDCs exhibit a distinct 
immediate glycolytic burst upon activation with TLR ligands. This 
provides a rapid and sensitive method to detect whether BMDCs were 
actively recognizing and responding to a particular adjuvant 
formulation46. Resting BMDCs were measured for baseline glycolytic 
activity and then exposed to LPS, PBC micelle, or medium control. 
Medium acidification rates were recorded as a measure of glycolytic 
activity. Immediately upon exposure to LPS, BMDCs exhibited an 
increase in glycolytic rate, while exposure to the micelle 
formulation showed levels of glycolysis similar to the control 
over the course of the assay (Figure 6A). 
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Figure 6. Treatment of BMDCs with pentablock copolymer (PBC) 
micelles did not induce a glycolytic shift in their metabolic 
profile. A) Kinetic stimulation test and B) Mitochondrial stress 
test for BMDCs stimulated with different treatment groups (PBC 
micelles at the concentration of 12.5 μg/mL and LPS at 1 μg/mL) 
was performed overnight using extracellular flux analysis . 
Extracellular acidification rate (ECAR) and oxygen consumption 
rate (OCR) are represented by millipH/min and pmol/min. The figure 
on top right represents ECAR value at 61 minutes and figures in 
the bottom right represent different measures of the mitochondrial 
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respiration derived from B as indicated in the text using standard 
methods. * indicates p<0.02, ** indicates p<0.002 and *** indicates 
p<0.0002. n=2. 
To evaluate the metabolic consequences of exposure of BMDCs to 
PBC micelles, we probed mitochondrial respiratory function with a 
mitochondrial stress test (Figure 6B). Several parameters, such as 
basal respiration, ATP production, maximum respiration and spare 
capacity were measured using sequential injections of different 
drugs47. Addition of oligomycin, an inhibitor of ATP synthase, 
complex V, provided the ATP production rate. The addition of FCCP, 
which is a protonophore drives the ETC to function at its maximal 
rate, provided the maximal and spare respiratory capacity of the 
cells. Addition of rotenone, which shuts down the ETC provided the 
rate of non-mitochondrial respiration to be subtracted. We found 
that all these parameters for BMDCs stimulated with micelles were 
not different from the control cells, while stimulation with LPS 
led to decreased ATP turnover and decreased respiratory capacity 
(Figure 6B). 
PBC micelles do not induce detrimental ROS and NO production by 
APCs
Upon encounter with a pathogen or MAMPs, cells of the innate 
immune system induce the production of antimicrobial innate 
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effector molecules48,49. These largely consist of various types of 
reactive oxygen and reactive nitrogen species. Since little to no 
upregulation of costimulatory molecules or increases in pro-
inflammatory cytokine secretion was exhibited in response to the 
PBC micelles, we sought to determine if there was induction of ROS 
and NO in APCs upon encounter with the micelles. NO production was 
quantified from supernatants collected from BMDCs stimulated with 
micelle, LPS, or unstimulated controls and quantified via Griess 
assay. After 48 hours of stimulation, LPS stimulation resulted in 
a marked accumulation of nitrite in the supernatants while PBC 
micelle stimulation resulted in no accumulation of nitrite (Figure 
7A). Similar results were observed in BMMs and J774 stimulations 
(SI Figure 5). BMDCs were also analyzed for mitochondrial 
superoxide and cytosolic ROS production. Similar patterns were 
observed in that LPS induced the production of large amounts of 
both superoxide and cytosolic ROS while stimulation with PBC 
micelles resulted in no measurable increase in the production of 
these molecules (Figures 7B and C).
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Figure 7. Pentablock copolymer (PBC) micelle adjuvants did not 
induce the production of NO or ROS by APCs. A) Nitric oxide 
production by BMDCs, B) BMDC mitochondrial superoxide production, 
and C) Reactive oxygen species production in the BMDC cytosol were 
measured in the supernatants and cells stimulated with the 
treatment groups (PBC micelles at the concentration of 12.5 μg/mL 
and LPS at 1 μg/mL) for 48 hours using Griess assay and flow 
cytometry. Data is expressed as mean with standard error of mean. 
Statistical differences were determined using one-way ANOVA. * 
indicates p<0.01 and **** indicates p<0.0001. n=3.
Discussion
Adjuvants have played a major role in enhancing vaccine 
efficacy1,21,50. The mechanisms of action of adjuvants range from 
creating a depot, induction of inflammation, controlled release of 
antigen, and acting as DAMPs. There has been a significant amount 
of research on synthesizing new adjuvants, understanding their 
mechanism(s) of action, and improving them for different 
applications51. There are multiple viewpoints on the desirable 
characteristics of next generation vaccine adjuvants51–53. There is 
a need to design new adjuvants and understand and exploit their 
immunomodulatory properties to specifically suit certain types of 
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host immune systems, such as those of older adults and 
immunocompromised patients.
In this work, we showed that amphiphilic PBC micelle-based 
adjuvants can act as effective carriers for enhanced delivery of 
antigens to APCs and induce robust adaptive immunity without the 
production of NO and superoxides linked to the generation of an 
overt inflammation. Hydrogels formed by PDEAEM and Pluronic F127®-
based PBCs have been previously demonstrated to induce robust 
antibody responses as vaccine adjuvants and vaccines formulated 
with these materials effectively protected animals against viral 
challenge29,54. In the present work, we demonstrated that immunizing 
animals (C57BL/6 mice) with PBC micelles, at a significantly lower 
polymer concentration than previously reported55, enhanced anti-
Ova antibody titers in mice (Figure 1) when compared to sOva alone. 
Though the antibody titers were still significant at 4 weeks p.i. 
compared to sOva alone, we observed a slight decrease in titers 
from 2 weeks to 4 weeks p.i. Our hypothesis is that the antigen-
containing micelles may facilitate crosslinking the B cell 
receptor (BCR) and provide a rapid and low affinity antibody 
response56,57. This may be beneficial for presentation of the 
antigen or a co-adjuvant to the receptors of immune cells in 
orientations exposing certain conformational epitopes of the 
antigen to crosslink multiple BCRs and provide an initial high 
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burst of antigen, resulting in rapid induction of antibody; 
however, another adjuvant in combination with the micelles may be 
required for induction of robust long-lasting immunity58. We also 
observed similar trends in enhancement of humoral immunity and 
improved vaccine efficacy with influenza antigens 2 and 4 weeks 
p.i. for PBC micelles alone and in combination with another vaccine 
adjuvant, polyanhydride nanoparticles54. We repeated the experiment 
with Ova adjuvanted with micelles administered to BALB/c mice and 
observed similar enhancement in antibody responses (data not 
shown). 
From previous studies, we had concluded that both the depot effect 
formed by hydrogels and the outer cationic blocks of the polymer 
contributed to enhanced antibody titers55. Since the PBC micelle 
concentration used in the present studies do not form a depot at 
the injection site, unlike the hydrogels, we hypothesize that the 
observed enhancement in humoral immunity may be attributed to the 
association of the antigen and the PBC micelles. There is 
significant interest in designing vaccine carriers to enhance 
cytosolic uptake of antigens resulting in enhanced presentation 
via the MHC I pathway and induction of CD8+ T cell responses53,59. 
In this context, pH-responsive polycationic gene delivery systems, 
such as the PBC micelles, are known to translocate DNA from the 
endosome to the cytosol by induction of the endosomal escape of 
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associated gene using a proton sponge effect15,60. Hence, we studied 
if these micelles associate with antigen in a similar manner and 
deliver them to the cytosol. 
We observed intracellular localization of the micelles and the 
associated ovalbumin into the cytosol of both BMDCs and J774 cells 
starting at an incubation period of 30 min and lasting until 12 
hours (Figure 2, SI Figure 1 and 2 ). Ova is known to be 
internalized after 15 min of incubation with APCs61. However, we 
did not observe a significant amount of internalization by the 
cells incubated with PBC micelles plus Ova in the first 15 min in 
either BMDCs or J774 cells (SI Figure 2 and 3). Other studies have 
shown that subsequently increasing amounts of Ova are detected 
after 15 min in the cytosol due to endosomal escape caused by the 
association with the carrier17. We showed association of Ova with 
the PBC micelles by FRET, in which energy transfer between 
fluorophores takes place in a non-radiative manner when they are 
separated by a distance referred to as the Forster radius for the 
two dyes (8.5 nm for our fluorophore system)62–64. We observed the 
transfer of energy from donor to acceptor using the spectral 
emission curve at specific concentrations of the antigen and the 
micelles in solution (Figure 3). A similar technique was utilized 
previously for studying complexation of DNA with the PBC 
micelles37,65. We utilized the same concentrations for studying FRET 
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in vitro with APCs using sensitized emission and a confocal 
microscope. Even though we did not calculate the numerical value 
of FRET efficiency, the FRET index image demonstrated the degree 
of FRET occurring quantitatively. The areas of strong association 
of the micelles with Ova as indicated by the FRET index image 
(Figure 4) within the cytosol indicated that the micelles 
transported the antigen to the cytosol. This hypothesis was 
supported by the FACS analysis, which quantitatively demonstrated 
enhanced uptake of Ova by BMDCs when associated with micelles 
rather than when delivered alone. Starting at 60 min of incubation 
with cells, the amount of Ova internalized steadily increased over 
12 hours of incubation. (Figure 4C and SI Figure 3). It is also 
worthwhile to note that we observed both stronger association of 
micelles with Ova and enhanced uptake of Ova in BMDCs than in J774 
cells. The micelles appeared to be localized more around the cell 
membranes of the cells. Some studies have demonstrated that 
amphiphilic molecules such as Pluronic can incorporate themselves 
into the lipid bilayer of the membranes and facilitate protein 
transport across it66,67. 
All these observations have particular relevance to the rational 
design of vaccine formulations for older adults and 
immunocompromised populations. The current strategy in commercial 
vaccines for older adults (e.g., high dose Fluzone) is to deliver 
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four times the amount of vaccine dose as the normal dose. In this 
context, the ability of the PBC micelles to increase the overall 
antigen internalization can be beneficial for vaccine delivery in 
older adults68. 
Many adjuvants or immune potentiators, including the licensed 
adjuvant MPLA, act via the engagement of various receptors on 
innate immune cells and their stimulation, which can be measured 
by the upregulation of cell surface marker expression and cytokine 
secretion69. However, for PBC micelles, as demonstrated in Figure 
5 and SI Figure 2, we did not observe any significant upregulation 
of these markers. Therefore, it appears that these micelles do not 
act as traditional immune stimulants or innate immune cell 
activators, such as TLR ligands. Indeed, the activation of APCs 
through TLRs may not always be desirable, especially when TLR 
agonists induce excessive NO production, which can cause cellular 
stress and contribute to acute inflammatory state of the immune 
system49,70,71. Higher amounts of NO production by inflammatory 
immune cells has been linked to lower B cell activation, diminished 
antibody responses, lower class-switiching, and generation of more 
short-lived plasma cells then long-lived plasma cells10,72. In 
contrast, administration of PBC micelles did not lead to the 
production of NO or any cellular or mitochondrial ROS (Figure 7 
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and SI Figure 3) while still enhancing antibody production (Figure 
1). 
Finally, an analysis of the metabolic profile of APCs stimulated 
with the PBC micelles demonstrated low mitochondrial stress when 
compared to LPS (Figure 6). Rapid glycolytic activity as 
demonstrated by the TLR agonists in extracellular flux analysis 
has been reported to contribute to inflammation73. In a separate 
study using cathepsin activity, we have demonstrated that micelles 
do not induce inflammation at the site of injection31. Combined 
with the glycolytic activity of the micelles demonstrated in this 
work (Figure 6), this suggests that a potential benefit of micelle 
adjuvants would be to avoid adverse inflammatory reactions.
Overall, all these findings demonstrate that these PBC micelles, 
while not activating APCs in a way that traditional TLR agonists 
do, can still act as effective adjuvants for enhancing antibody 
responses in the context of low inflammation and increasing antigen 
trafficking into the cytosol of APCs. Given the enhanced 
intracellular localization of antigen in the presence of the PBC 
micelles, this observation is likely beneficial for designing an 
effective vaccine regimen to enhance host immune responses that 
have impaired APC functionality due to underlying inflammation and 
potentially to induce cytotoxic T cell responses.
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CONCLUSIONS
In this work, we demonstrated that a low concentration of an 
amphiphilic pentablock copolymer that undergoes pH sensitive 
micellization in aqueous solution can enhance adaptive immune 
responses in mice without forming a gel depot. We showed that the 
PBC micelles associate with antigens and deliver them to the 
cytosol of APCs. We also demonstrated that these PBC micelles are 
different from traditional TLR agonists in terms of their 
activation of APCs as evidenced by the lack of co-stimulatory 
molecule expression, cytokine secretion, induction of NO and ROS, 
and immunometabolic profiles. Therein, we found that PBC micelle-
based nanoadjuvants do not generate mitochondrial stress and do 
not create a harmful inflammatory environment. These attributes 
make the PBC micelle adjuvants attractive candidates in the design 
of vaccines for older adults and immunocompromised patients. 
Supporting Information Available
The following files are available free of charge:
Figure S1. Mean fluorescence intensity (MFI) of micelle-positive  
A) BMDCs and B) J774 cells. Cells were stimulated with 12.5 µg/mL 
of PBC micelles labeled with AF647 for multiple time-points, washed 
and fixed in FACS buffer. Internalization was measured using flow 
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cytometry and the MFI was determined using FlowJo software. A 
representative histogram demonstrating the shift in the cell 
population treated with micelles (shown in gray, solid outline) 
compared to control (shown in black, dotted outline) is shown for 
C) BMDCs and D) J774 cells after 12-hour (720 min) incubation. 
Data representative of three independent experiments and indicated 
as mean with standard error of mean.
Figure S2. Trafficking of antigen into A) BMDCs and B) J774 cells 
incubated for 15 min with pentablock copolymer (PBC) micelles (12.5 
µg/mL) and antigen (20 μg/mL); C) BMDCs and D) J774 cells incubated 
for 2 hours with PBC micelles and antigen. Cells seeded at a 
concentration of 2.5  106 cells/mL on glass coverslips were 
incubated with the micelles and ovalbumin for the required amount 
of time. Scale bars indicate A)  50 μm and B), C) and D) 5 μm. 
Nuclei were stained with Hoescht (blue). Ovalbumin antigen (AF594) 
and PBC micelles (AF647) are denoted by red and cyan, respectively. 
Data are representative of three independent experiments.
Figure S3. Time-course of the ovalbumin uptake when incubated with 
pentablock copolymer (PBC) micelles for A) BMDCs and B) J774 cells. 
The cells were  incubated with the micelle-Ova complexes, micelle 
formulation, Ova formulation and unstimulated control for the 
indicated times and the protein mean fluorescence  intensity (MFI) 
was calculated using FlowJo software. Data represented as mean 
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with standard error of mean. **indicates statistical significance 
determined using unpaired t-test with p<0.002, n=3
Figure S4. Pentablock copolymer (PBC) micelles did not show 
significant upregulation of costimulatory molecules in bone marrow 
macrophages and did not induce pro-inflammatory cytokine 
secretion. BMMs at a concentration of 2.5  106 cells/mL were 
stimulated for 48 hours with micelle or LPS (PBC micelles at the 
concentration of 12.5 μg/mL and LPS at 1 μg/mL) . Cell surface 
markers, MHCII, CD80 and CD40 upregulation were analyzed using 
flow cytometry and cytokine secretion in supernatants were 
analyzed using Multiplex bead assay. Data represented as mean with 
standard error of mean. Statistical significance indicated by 
**p<0.005 and ***p<0.0005. n=3.
Figure S5. PBC micelle adjuvants do not induce nitric oxide in 
J774 cells and bone marrow macrophages. Cells were stimulated with 
micelles and controls for 48 hours. Supernatants were collected to 
analyze NO production using Griess assay. Data represented as mean 
nitrile production with standard error of mean. **** indicates 
statistical significance with p<0.0001.
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